BG62036B1 - Нов биоактивен състав, неговото получаване и използването му - Google Patents

Нов биоактивен състав, неговото получаване и използването му Download PDF

Info

Publication number
BG62036B1
BG62036B1 BG99360A BG9936095A BG62036B1 BG 62036 B1 BG62036 B1 BG 62036B1 BG 99360 A BG99360 A BG 99360A BG 9936095 A BG9936095 A BG 9936095A BG 62036 B1 BG62036 B1 BG 62036B1
Authority
BG
Bulgaria
Prior art keywords
polyoxyethylene glycol
lactose
lactic acid
symptoms
magnesium sulfate
Prior art date
Application number
BG99360A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG99360A (bg
Inventor
Gyoergy Hangay
Gaborne Olah
Edit Tokos
Gyoergy Vamos
Erno Mehesz
Ernone Mehesz
Original Assignee
Vepex Kft.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vepex Kft. filed Critical Vepex Kft.
Publication of BG99360A publication Critical patent/BG99360A/bg
Publication of BG62036B1 publication Critical patent/BG62036B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BG99360A 1992-07-22 1995-01-20 Нов биоактивен състав, неговото получаване и използването му BG62036B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9202398A HU212426B (en) 1992-07-22 1992-07-22 Process for producing bioactive pharmaceutical compositions
PCT/HU1993/000016 WO1994002148A1 (en) 1992-07-22 1993-03-18 Novel bioactive compositions, preparation and use thereof

Publications (2)

Publication Number Publication Date
BG99360A BG99360A (bg) 1995-12-29
BG62036B1 true BG62036B1 (bg) 1999-01-29

Family

ID=10982190

Family Applications (1)

Application Number Title Priority Date Filing Date
BG99360A BG62036B1 (bg) 1992-07-22 1995-01-20 Нов биоактивен състав, неговото получаване и използването му

Country Status (18)

Country Link
US (1) US5622927A (fi)
EP (1) EP0651641B1 (fi)
JP (1) JPH08501533A (fi)
KR (1) KR950702421A (fi)
AT (1) ATE170752T1 (fi)
AU (1) AU688260B2 (fi)
BG (1) BG62036B1 (fi)
CA (1) CA2140630A1 (fi)
CZ (1) CZ283011B6 (fi)
DE (1) DE69320968T2 (fi)
FI (1) FI950290A0 (fi)
HU (1) HU212426B (fi)
NZ (1) NZ251424A (fi)
PL (1) PL171031B1 (fi)
RO (1) RO111735B1 (fi)
RU (1) RU2117479C1 (fi)
SK (1) SK279276B6 (fi)
WO (1) WO1994002148A1 (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1062111C (zh) * 1995-12-06 2001-02-21 李启荣 杂交水稻制种花期花时调节剂
US5750122A (en) * 1996-01-16 1998-05-12 The Procter & Gamble Company Compositions for treating hair or skin
ATE304362T1 (de) 1997-11-24 2005-09-15 Zhongming Zeng Pharmazeutische zusammensetzung zur stimulierung des wachstums von gram-positiven bazillen und zur erhöhung der azidität der vagina und ihre verwendung
US6964949B2 (en) 2000-05-24 2005-11-15 Shanghai Jiao Da Onlly Co., Ltd. Pharmaceutical compositions for promoting the growth of gram-positive bacilli and increasing the acidity in the vagina and the use thereof
US7205320B2 (en) * 2001-01-22 2007-04-17 Memory Pharmaceuticals Corp. Phosphodiesterase 4 inhibitors
ITMI20010913A1 (it) * 2001-05-04 2002-11-04 Univ Pavia Composizioni a rilascio controllato di acido lattico a livello vaginale
US6589216B1 (en) 2002-02-20 2003-07-08 Abbott Research Group, Inc. Vaginal douches, vaginal douche applicators and methods of vaginal douching
US8118789B2 (en) * 2002-02-20 2012-02-21 Abbott Research Group, Inc. Deodorizer devices and systems for controlling perspiration-related body odor
US7270653B2 (en) * 2002-02-20 2007-09-18 Abbott Research Group Methods of treating abnormal biological conditions using metal oxides
US20050271746A1 (en) * 2004-05-18 2005-12-08 Abbott Chun L Topical treatments for abnormal biological conditions and method of topically treating such conditions
JP4807972B2 (ja) * 2005-06-01 2011-11-02 株式会社池田模範堂 皮膚外用剤
KR101133723B1 (ko) * 2009-10-19 2012-04-09 최원석 소금 및 당을 유효성분으로 함유하는 질염 예방 및 치료용 조성물 및 이의 용도
AU2011243967B2 (en) * 2010-04-21 2015-08-20 Mileutis Ltd. Casein peptide for use in the treatment of uterine infections

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE35991B1 (en) * 1971-01-22 1976-07-21 Comprehensive Pharmaceuticals Improvements in or relating to the treatment of diseases of the skin and mucosa
DE3011437A1 (de) * 1980-03-25 1981-10-01 Hrvoje Dr. Zagreb Krnjevic Pharmazeutisches mittel zur heilung von entzuendlichen und/oder degenerativen und/oder atrophischen schleimhauterkrankungen
US4393066A (en) * 1981-06-05 1983-07-12 Garrett David M Method for treatment of herpetic lesions
US4628063A (en) * 1984-03-08 1986-12-09 Dana P. Brigham Antiviral pharmaceutical preparations and methods for their use
US4665069A (en) * 1985-04-02 1987-05-12 Barnett Rosenberg Analgesic composition and method of relieving pain
WO1988004927A1 (en) * 1986-12-31 1988-07-14 Davirand, Inc. Compositions and formulations containing folic acid, method of treating tissue with folic acid and method for preparing compositions and formulations of folic acid
US5466680A (en) * 1992-03-26 1995-11-14 Cytologics, Inc. Method and compositions for enhancing white blood cell functioning on a mucosal or cutaneous surface

Also Published As

Publication number Publication date
WO1994002148A1 (en) 1994-02-03
CZ15395A3 (en) 1995-09-13
PL307256A1 (en) 1995-05-15
FI950290A (fi) 1995-01-23
KR950702421A (ko) 1995-07-29
RU2117479C1 (ru) 1998-08-20
JPH08501533A (ja) 1996-02-20
EP0651641B1 (en) 1998-09-09
NZ251424A (en) 1997-06-24
SK7795A3 (en) 1995-07-11
DE69320968T2 (de) 1999-04-15
EP0651641A1 (en) 1995-05-10
FI950290A0 (fi) 1995-01-23
CZ283011B6 (cs) 1997-12-17
PL171031B1 (pl) 1997-02-28
HUT64840A (en) 1994-03-28
SK279276B6 (sk) 1998-09-09
US5622927A (en) 1997-04-22
HU212426B (en) 1996-06-28
RO111735B1 (ro) 1997-01-30
BG99360A (bg) 1995-12-29
HU9202398D0 (en) 1992-10-28
CA2140630A1 (en) 1994-02-03
AU3903193A (en) 1994-02-14
AU688260B2 (en) 1998-03-12
DE69320968D1 (de) 1998-10-15
ATE170752T1 (de) 1998-09-15

Similar Documents

Publication Publication Date Title
RU2403012C2 (ru) Мукоадгезивные ксилоглюкансодержащие препараты, полезные в медицинских устройствах и в фармацевтических препаратах
De Sanctis et al. Growth and development in thalassaemia major patients with severe bone lesions due to desferrioxamine
NL192821C (nl) Oftalmische oplossing.
BG62036B1 (bg) Нов биоактивен състав, неговото получаване и използването му
KR910005885B1 (ko) 염화리소짐 및 글리치르히진산 디칼륨 함유 수용액제제
US20100021563A1 (en) Compositions comprising coconut oil and methods of use thereof
TWI719046B (zh) 軟性抗膽鹼類似物之製劑
CN114423412A (zh) 包含大麻二酚的外用制剂、制备组合物的方法及其用途
EP0140998B1 (en) Ophthalmic preparations
JPH08505388A (ja) ヒアルロン酸−尿素医薬組成物およびその使用
JPS6227A (ja) 皮膚科ならびに眼科用の外傷、潰瘍治療用クリーム剤
US5371107A (en) Use of ascorbic acid in the genital area and corresponding medicinal preparations
JP2000512270A (ja) 単純ヘルペスの処置のための組成物および方法
EP0620737B1 (en) Use of LACTOFERRIN iN the manufacture of a medicament for treating RHEUMATISM
US5552436A (en) Process for treating hemangioma
EP2771013B1 (en) Topical pharmaceutical compositions comprising acyclovir and hyaluronic acid
JPH02304032A (ja) 非イオン界面活性剤含有局所抗ウイルス医薬組成物
US3894153A (en) Method of medical treatment of asthma
EP0297630A1 (de) Arzneimittel, enthaltend Lokalanästhetika und Nukleoside
HU207446B (en) Method for producing medicinal preparation of local use
AXELROD Idiopathic hypoparathyroidism: unusual response to vitamin D
US20240108648A1 (en) Storage stable formulations of sulfated glycosaminoglycans and fragments derived therefrom for the treatment of pain and other medical conditions
CN117100830A (zh) 一种有利于缓解疼痛的植物提取复合物及含有复合物的舒痛霜
EP0396169A2 (en) Pharmaceutical composition for topical ophthalmic use having improved local tolerability
Getaz, EP & Staples Idiopathic thrombocytopenic purpura and hyperthyroidism-a case report